glp-1 news today 2025 november updates supply shortage ISPOR 2025: Exploring reasons for discontinuation GLP-1 Drugs Driving Protein Demand – GLP-1 RA prescription trends: January – Can a GIP/GLP-1 dual receptor

With around 10 million obese adults in the UK, once the drugs become cheaper than GBP 95 per month, it becomes beneficial for the UK government to buy GLP-1 drugs and make them available for free to eligible patients

They are most often used together because pressing both receptors at once produces a larger GH pulse than either one alone

Now Owned by Danone, Kate Farms Targets Ozempic with High-Protein Plant-Based Nutrition Shakes Plant-based nutrition brand Kate Farms has launched two high-protein shakes to tackle critical nutrition gaps from GLP-1 use, its first product since its acquisition by Danone

Monitoring and Assessment Protocols Comprehensive monitoring is essential when researching cagrilintide dosage protocols, particularly when exploring combinations with other peptides